Welcome to our dedicated page for Lifeway Food news (Ticker: LWAY), a resource for investors and traders seeking the latest updates and insights on Lifeway Food stock.
Lifeway Foods Inc. reports developments tied to its kefir-centered fermented dairy business. The company manufactures and markets drinkable kefir, Organic Lifeway Kefir, farmer cheese, other cheeses, ProBugs products for children, frozen kefir and private-label dairy items through retail, broker and distributor channels.
Recurring news themes include financial results and sales outlooks, growth in kefir and farmer cheese demand, product collaborations with foodservice and wellness partners, and brand campaigns that position kefir as a protein-forward probiotic beverage. Company updates also cover distribution, product innovation and consumer-marketing activity across its fermented probiotic portfolio.
Lifeway Foods, Inc. (Nasdaq: LWAY) reported record net sales of $141.5 million for 2022, marking an 18.9% year-over-year increase and a 51.1% rise compared to 2019. This achievement represents the 13th consecutive quarter of growth in net sales. The growth was primarily driven by increased sales of their branded drinkable kefir and price adjustments. Despite rising costs, gross profit was 18.9% of net sales, with selling expenses lower at 16.9%. However, net income decreased to $0.9 million from $3.3 million in 2021. The company plans to pursue further distribution and marketing efforts in 2023.
Lifeway Foods, Inc. (NASDAQ: LWAY), a prominent U.S. supplier of kefir and probiotic products, will announce its financial results for the fourth quarter and full year ending December 31, 2022. The report is scheduled for March 27, 2023, after market hours. Following the results, a conference call led by CEO Julie Smolyanksy will be available on the company's Investor Relations webpage. Lifeway, recognized as one of Forbes' Best Small Companies, offers a diverse range of products, including drinkable kefir, cheese, and probiotic oat milk, available across the U.S., Mexico, Ireland, and France.
Lifeway Foods, Inc. (Nasdaq: LWAY) announced that CEO Julie Smolyansky will speak at the SXSW Conference in Austin, Texas, on March 12, 2023, at 2:30 PM CT. The session, titled "It Takes Guts: From Ukrainian Refugee to Kefir CEO", features Smolyansky and journalist Jessica Yellin, discussing leadership, community support, and the health benefits of kefir. Smolyansky took over as CEO at age 27 after her father's passing in 2002, guiding Lifeway's growth and innovation in the probiotic beverage market. The discussion will be held at the Austin Marriott Downtown and is open to all SXSW attendees.
Lifeway Foods, Inc. (NASDAQ: LWAY) announced the launch of exciting new kefir flavors at Natural Products Expo West 2023, held from March 7-11 in Anaheim, CA. The new offerings include Guava Lowfat Kefir, Organic Strawberry Banana Whole Milk Kefir, and Organic Black Cherry Whole Milk Kefir, alongside seasonal flavors like Rainbow Cake and Campfire S'mores. All products are made with non-GMO ingredients and are up to 99% lactose-free. Consumers can sample these innovative flavors before their retail release in April. CEO Julie Smolyansky will also sign her cookbook at the expo, highlighting the brand's commitment to health and nutrition.
Lifeway Foods, Inc. (Nasdaq: LWAY), a prominent supplier of kefir and probiotic products, announced participation in the 25th Annual ICR Conference in Orlando, Florida on January 10, 2023. Julie Smolyansky, President and CEO, will present at 8:00 AM ET, with a live webcast available for replay on the company's investor relations website. Lifeway Foods is recognized for its fermented products sold in the US, Mexico, Ireland, and France, offering a variety of beverages and snacks for health-conscious consumers.
Lifeway Foods (LWAY) reported a remarkable 29.1% increase in net sales for Q3 2022, reaching $38.1 million, marking the 12th consecutive quarter of year-over-year growth. This growth was driven by strong sales of their kefir products and price increases from early 2022. The company achieved a net income of $1.0 million, translating to $0.06 per share. Despite rising expenses, Lifeway aims to expand distribution and marketing efforts, particularly within the convenience channel, as they prepare for a strong finish to 2022 and a promising 2023.
Lifeway Foods, Inc. (Nasdaq: LWAY) will announce its third quarter financial results for the period ending September 30, 2022, on November 14, 2022, before market hours. A pre-recorded conference call and webcast featuring CEO Julie Smolyansky will offer further details and insights into the Company’s performance, available on their Investor Relations webpage. Lifeway is recognized as a leading supplier of kefir and fermented probiotic products in the U.S., with products sold across several countries including Mexico, Ireland, and France.
Lifeway Foods reported a net sales increase of 14.8% year-over-year to $33.5 million for Q2 2022, marking its 11th consecutive quarter of growth. The rise was driven by higher sales volumes of drinkable kefir and price increases. Despite inflationary pressures, consumer demand remains strong, demonstrated by expanded distribution and sales velocities. The gross profit margin was 17.0%, while net income was $0.1 million or $0.01 per share. The company faced delays in reporting financial results but remains optimistic about growth opportunities.
Lifeway Foods, a leader in probiotic products, reported a 16.1% increase in net sales year-over-year, reaching $34.1 million for Q1 2022. This marks the 10th consecutive quarter of sales growth, driven by strong demand for their drinkable Kefir and price increases. The company remains optimistic about future growth, focusing on expanding distribution in retail and away-from-home locations. However, the reporting of financial results faced delays, impacting the filing of their 10-K and 10-Q reports.
Lifeway Foods, Inc. (Nasdaq: LWAY) received a notice from Nasdaq on August 23, 2022, indicating non-compliance with Listing Rule 5250(c)(1) due to delayed filings of its Quarterly Reports for Q1 and Q2 of 2022. This follows an earlier notice about the untimely filing of its Annual Report for 2021. The Company must submit a compliance plan by September 7, 2022, potentially receiving an extension up to 180 days to file necessary reports. Lifeway is actively working to meet these requirements and regain compliance.